The H9 antigen in Avian Influenza Virus (AIV) is another important serotype, especially the H9N2 subtype, which has a significant impact on poultry and is also a potential threat to humans.

Characteristics and antigenicity

Characteristics

Genomic structure:

The H9 antigen belongs to the Influenza A Virus, whose genome consists of eight single-stranded negative-stranded RNA segments, each encoding one or more proteins.

The H9 antigen mainly involves the Hemagglutinin (HA) protein, which is responsible for viral adhesion and entry into host cells.

Hemagglutinin protein:

The HA protein is a glycoprotein on the surface of the virus and is classified into 16 serotypes (H1-H16), of which H9 is one.

HA proteins are responsible for binding to receptors on the surface of host cells and mediate viral entry into the cell.

Antigenic Mutation:

Avian influenza viruses are prone to antigenic drift and antigenic switching, leading to the emergence and prevalence of new subtypes.H9N2 is one of the most representative and widespread H9 subtypes.

Immunogenicity: H9 antigens are highly immunogenic and can induce the host to produce neutralising antibodies against HA proteins. Neutralising antibodies prevent the virus from entering host cells, thus providing immune protection.

Cross-reactivity:

There may be some crossimmune response between different H9 subtypes, but usually the cross-protection is limited.

Immune escape is more prevalent due to antigenic variability, posing a challenge to vaccine development.

Clinical symptoms and disease severity

Symptoms in poultry

Low Pathogenic Avian Influenza (LPAI):

Mild symptoms: Poultry infected with H9N2 viruses usually show mild respiratory symptoms such as coughing, sneezing, and lacrimation.

Decreased egg production: Infected hens show a significant decrease in egg production and deterioration in eggshell quality.

Loss of appetite: sick birds lose appetite and are depressed.

Complications: other bacterial or viral infections may complicate and aggravate the disease.

Highly pathogenic avian influenza (HPAI):

The H9 subtype is generally not highly pathogenic, but in some cases, poultry infected with H9N2 may show more severe symptoms, especially when co-infections with other pathogens are present.

Symptoms in humans

Mild respiratory infection:

Fever, cough, sore throat, nasal congestion, runny nose, and other cold-like symptoms.

Severe symptoms: less common, but may lead to severe symptoms such as severe pneumonia and acute respiratory distress syndrome.

Routes of transmission

Direct contact:

Poultry-to-poultry transmission: through direct contact with infected poultry or their secretions and excretions.

Human-poultry contact: humans are infected with the virus through direct contact with infected poultry or their secretions and excretions.

Environmental transmission:

The virus can be spread indirectly through contaminated water, feed, utensils, etc.

Airborne transmission: the virus can be transmitted through airborne droplets, especially in confined and poorly ventilated environments.

Clinical Diagnosis

Clinical symptom observation:

Initial diagnosis based on typical symptoms in poultry or humans.

Laboratory tests:

PCR: Detection of viral RNA in respiratory samples by reverse transcription PCR (RT-PCR) is a rapid and sensitive test.

Virus isolation: Virus is isolated from sick birds or patient samples for culture and identification of the virus.

Serological testing: Detection of antibodies in serum using haemagglutination inhibition (HI) or enzyme-linked immunosorbent assay (ELISA) for assessment of infection and immune response.

Rapid diagnostic reagents: Use of rapid antigen detection kits for initial screening, but laboratory confirmation is required.

Preventive measures

Vaccination: Vaccinate poultry with avian influenza vaccine against the H9 subtype, especially in high-risk areas. Regularly update the vaccine strain to cope with antigenic variation of the virus.

Biosecurity measures: Strictly implement biosecurity measures including quarantine of newly introduced poultry, disinfection of personnel and equipment, and restriction of entry and exit of personnel and vehicles to poultry farms.

Regularly monitor the disease situation inside and outside the poultry farm and take timely preventive and control measures.

Management Measures

All-in-all-out: Adopt an all-in-all-out feeding management mode to avoid mixing different batches of poultry. It helps to reduce the spread of virus among poultry.

Isolation and quarantine: newly introduced poultry should be isolated and quarantined to ensure that they are not infected with H9 subtype virus. Regular health checks should be conducted to detect and treat infected poultry in a timely manner.

Personnel training: Raise awareness and preventive and control skills of keepers and veterinarians on H9 subtype avian influenza.

Therapeutic measures

There is no specific drug against H9 subtype avian influenza virus infection. The mainstay of treatment is symptomatic, providing supportive care and proper nutrition.

The use of antiviral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) may help to alleviate the symptoms but have limited effect.

Control measures

Culling of infected poultry: Rapidly cull infected and suspected infected poultry to prevent spread of the virus.

Thoroughly clean and disinfect contaminated environment, equipment and utensils.

Strict control of poultry trade: Restrict or prohibit the trade of poultry and poultry products in areas affected by the outbreak to prevent the spread of the virus.

Avian Influenza Virus H9 Antigen Rapid Test

Antigenne has developed the Avian Influenza Virus H9 Antigen Rapid Test, which is a fast, easy-to-use and highly accurate test that can effectively help users detect relevant viral infections.